Search Results
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Institute for Liver and Digestive Disease, Royal Free Hospital, University College London, London, UK
Search for other papers by Luohai Chen in
Google Scholar
PubMed
Search for other papers by Gopinath Gnanasegaran in
Google Scholar
PubMed
Search for other papers by Dalvinder Mandair in
Google Scholar
PubMed
Search for other papers by Christos Toumpanakis in
Google Scholar
PubMed
Search for other papers by Martyn Caplin in
Google Scholar
PubMed
Search for other papers by Shaunak Navalkissoor in
Google Scholar
PubMed
, increasing administered activity or considering alternative treatment. Several studies have assessed the potential role of prognostic markers, such as positivity or metabolic tumour volume on 18 F-fluorodeoxyglucose positron emission tomography ( 18 F
Search for other papers by W R Miller in
Google Scholar
PubMed
Search for other papers by T J Anderson in
Google Scholar
PubMed
Search for other papers by S White in
Google Scholar
PubMed
Search for other papers by D Evans in
Google Scholar
PubMed
Search for other papers by A Krause in
Google Scholar
PubMed
Search for other papers by J M Dixon in
Google Scholar
PubMed
for diagnosis may be analysed for predictive markers of response/resistance and related to volume changes of the same tumour during treatment and (iii) sequential samples can be taken from the tumour before, during and after treatment to monitor
Search for other papers by William R Doerfler in
Google Scholar
PubMed
Search for other papers by Alyaksandr V Nikitski in
Google Scholar
PubMed
Search for other papers by Elena M Morariu in
Google Scholar
PubMed
Search for other papers by N Paul Ohori in
Google Scholar
PubMed
Search for other papers by Simion I Chiosea in
Google Scholar
PubMed
Search for other papers by Michael S Landau in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Division of Endocrinology, University of Texas Medical Branch, Galveston, Texas, USA
Search for other papers by Pooja Manroa in
Google Scholar
PubMed
testing is being increasingly used in thyroid nodules with indeterminate cytology, including Hürthle cell nodules, to assist in the management of these patients ( Patel et al. 2018 , Steward et al. 2019 ). However, how the molecular markers of Hürthle
Search for other papers by S Tozlu in
Google Scholar
PubMed
Search for other papers by I Girault in
Google Scholar
PubMed
Search for other papers by S Vacher in
Google Scholar
PubMed
Search for other papers by J Vendrell in
Google Scholar
PubMed
Search for other papers by C Andrieu in
Google Scholar
PubMed
Search for other papers by F Spyratos in
Google Scholar
PubMed
Search for other papers by P Cohen in
Google Scholar
PubMed
Search for other papers by R Lidereau in
Google Scholar
PubMed
Search for other papers by I Bieche in
Google Scholar
PubMed
each subgroup of samples were characterized by their median values and ranges, rather than their mean values and coefficients of variation, and (b) relationships between the molecular markers and clinical and biological parameters were tested using the
Baylor College of Medicine, Departments of Molecular and Cellular Biology, Radiology, Lester and Sue Smith Breast Center, Houston, Texas, USA
Search for other papers by Wei Wei in
Google Scholar
PubMed
Baylor College of Medicine, Departments of Molecular and Cellular Biology, Radiology, Lester and Sue Smith Breast Center, Houston, Texas, USA
Baylor College of Medicine, Departments of Molecular and Cellular Biology, Radiology, Lester and Sue Smith Breast Center, Houston, Texas, USA
Search for other papers by Michael T Lewis in
Google Scholar
PubMed
Charafe-Jauffret et al . (2009) a Percentage estimated from bar graph. Researchers have tried to consolidate the discrepancy by applying different TIC markers to different molecular subtypes of breast cancers ( Ricardo et al . 2011 ) as well as by
Search for other papers by Kristian Unger in
Google Scholar
PubMed
Search for other papers by Johannes Wienberg in
Google Scholar
PubMed
Search for other papers by Andrew Riches in
Google Scholar
PubMed
Search for other papers by Ludwig Hieber in
Google Scholar
PubMed
Search for other papers by Axel Walch in
Google Scholar
PubMed
Search for other papers by Andreas Brown in
Google Scholar
PubMed
Search for other papers by Patricia C M O'Brien in
Google Scholar
PubMed
Search for other papers by Cäcilia Briscoe in
Google Scholar
PubMed
Search for other papers by Lindsey Gray in
Google Scholar
PubMed
Search for other papers by Elke Rodriguez in
Google Scholar
PubMed
Search for other papers by Gerhard Jackl in
Google Scholar
PubMed
Search for other papers by Jeroen Knijnenburg in
Google Scholar
PubMed
Search for other papers by Giovanni Tallini in
Google Scholar
PubMed
Search for other papers by Malcolm Ferguson-Smith in
Google Scholar
PubMed
Search for other papers by Horst Zitzelsberger in
Google Scholar
PubMed
, and usage as a therapeutic target or diagnostic/prognostic marker should be taken into consideration. Our study demonstrated that the molecular analysis of chromosomal breakpoints in radiation-transformed epithelial breast cell lines is able to
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Vivian Rosery in
Google Scholar
PubMed
Search for other papers by Henning Reis in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Konstantinos Savvatakis in
Google Scholar
PubMed
Search for other papers by Bernd Kowall in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Martin Stuschke in
Google Scholar
PubMed
General, Visceral and Transplantation Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Andreas Paul in
Google Scholar
PubMed
Department of Internal Medicine 6, Paracelsus Medical University, Nürnberg, Germany
Search for other papers by Alexander Dechêne in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by JiaJin Yang in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Ben Zhao in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Arianna Borgers in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Stefan Kasper in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Martin Schuler in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Phyllis F Cheung in
Google Scholar
PubMed
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Jens T Siveke in
Google Scholar
PubMed
prognostic value in highly proliferative GEP-NEN focusing on the inhibitory checkpoint molecules PD-1 and PD-L1, cytotoxic marker CD8, and tumor-associated macrophage (TAM) marker CD206. Spatial imaging was applied to illustrate the spatial distribution and
Search for other papers by Viktor Johanson in
Google Scholar
PubMed
Search for other papers by Håkan Ahlman in
Google Scholar
PubMed
Search for other papers by Peter Bernhardt in
Google Scholar
PubMed
Search for other papers by Svante Jansson in
Google Scholar
PubMed
Search for other papers by Lars Kölby in
Google Scholar
PubMed
Search for other papers by Fredrik Persson in
Google Scholar
PubMed
Search for other papers by Göran Stenman in
Google Scholar
PubMed
Search for other papers by Christina Swärd in
Google Scholar
PubMed
Search for other papers by Bo Wängberg in
Google Scholar
PubMed
Search for other papers by Mats Stridsberg in
Google Scholar
PubMed
Search for other papers by Ola Nilsson in
Google Scholar
PubMed
, the animals were carefully examined, and plasma and tumor tissues were collected for analysis of biochemical markers and morphological findings. Statistical analysis The correlations between GOT2 tumor weight and
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Lara Iglesias in
Google Scholar
PubMed
Search for other papers by Irene Halperin in
Google Scholar
PubMed
Search for other papers by Ángel Segura in
Google Scholar
PubMed
Search for other papers by Javier Martínez-Trufero in
Google Scholar
PubMed
Search for other papers by Maria Ángeles Vaz in
Google Scholar
PubMed
Search for other papers by Jesús Corral in
Google Scholar
PubMed
Search for other papers by Gabriel Obiols in
Google Scholar
PubMed
Search for other papers by Enrique Grande in
Google Scholar
PubMed
Search for other papers by Juan Jose Grau in
Google Scholar
PubMed
Search for other papers by Josep Tabernero in
Google Scholar
PubMed
Introduction Several translational and clinical studies have been designed based on the knowledge of the main molecular steps that lead to the transformation of the normal follicular cell into an invasive thyroid carcinoma, whose results are leading
Search for other papers by G Bidaux in
Google Scholar
PubMed
Search for other papers by M Roudbaraki in
Google Scholar
PubMed
Search for other papers by C Merle in
Google Scholar
PubMed
Search for other papers by A Crépin in
Google Scholar
PubMed
Search for other papers by P Delcourt in
Google Scholar
PubMed
Search for other papers by C Slomianny in
Google Scholar
PubMed
Search for other papers by S Thebault in
Google Scholar
PubMed
Search for other papers by J-L Bonnal in
Google Scholar
PubMed
Search for other papers by M Benahmed in
Google Scholar
PubMed
Search for other papers by F Cabon in
Google Scholar
PubMed
Search for other papers by B Mauroy in
Google Scholar
PubMed
Search for other papers by N Prevarskaya in
Google Scholar
PubMed
prostate cancer. It is therefore essential to understand what drives the progression to androgen-independence and identify the molecular markers for both the early androgen-dependent and the advanced androgen-independent prostate cancer stages. It